The event will focus on the forthcoming Joint Transnational Call (JTC2023) "Translational research on cancer epigenetics" and will gather up to 500 participants from research communities, enterprises, and hospitals in Europe, Canada, Taiwan, Israel and Turkey. Attending this event will provide you with the opportunity to engage with diverse stakeholders, share project ideas, and receive first-hand information about the TRANSCAN-3 Joint Transnational Call 2023.